-
Something wrong with this record ?
Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro
L. Schröterová, A. Ježková, E. Rudolf, K. Caltová, V. Králová, V. Hanušová,
Language English Country Greece
Document type Journal Article
NLK
Free Medical Journals
from 2006 to 1 year ago
ProQuest Central
from 2012-01-01
Medline Complete (EBSCOhost)
from 2014-06-01
Nursing & Allied Health Database (ProQuest)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
PubMed
30066850
DOI
10.3892/ijo.2018.4488
Knihovny.cz E-resources
- MeSH
- Cell Adhesion drug effects MeSH
- Neoplasm Invasiveness prevention & control MeSH
- Colorectal Neoplasms drug therapy pathology MeSH
- Phytic Acid pharmacology therapeutic use MeSH
- Humans MeSH
- Biomarkers, Tumor metabolism MeSH
- Cell Line, Tumor MeSH
- Cell Movement drug effects MeSH
- Disease Progression MeSH
- Antineoplastic Agents pharmacology therapeutic use MeSH
- Drug Screening Assays, Antitumor MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present study attempted to characterize the effect of IP6 on the migration and adhesion of colon cancer SW620 cells. IP6 was assessed at concentrations of 0.2 and 1 mM during 12, 24 and 48 h of exposure. Migration ability was measured with the real-time xCELLigence Real-Time Cell Analyzer Dual Purpose system. The expression of mRNA and proteins involved in migration and cancer progression [epithelial cell adhesion molecule, intercellular adhesion molecule-1, β-catenin, N-cadherin, E-cadherin, matrix metalloproteinase (MMP)-2 and MMP-9] was determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis. The changes in the expression and subcellular localization of E-cadherin were determined by indirect immunofluorescence. IP6 induced a decrease in the migration ability of the tested SW620 cell line. IP6-treated cells also showed decreased expression of N-cadherin, increased levels of E-cadherin and decreased expression of MMP-2 and MMP-9. These results indicated that IP6 has potential to modulate the migration ability and expression of markers associated with invasion in SW620 cells; however, further analysis is necessary to obtain a detailed understanding of the mechanism of action.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000503
- 003
- CZ-PrNML
- 005
- 20190121103836.0
- 007
- ta
- 008
- 190107s2018 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijo.2018.4488 $2 doi
- 035 __
- $a (PubMed)30066850
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Schröterová, Ladislava $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
- 245 10
- $a Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro / $c L. Schröterová, A. Ježková, E. Rudolf, K. Caltová, V. Králová, V. Hanušová,
- 520 9_
- $a Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present study attempted to characterize the effect of IP6 on the migration and adhesion of colon cancer SW620 cells. IP6 was assessed at concentrations of 0.2 and 1 mM during 12, 24 and 48 h of exposure. Migration ability was measured with the real-time xCELLigence Real-Time Cell Analyzer Dual Purpose system. The expression of mRNA and proteins involved in migration and cancer progression [epithelial cell adhesion molecule, intercellular adhesion molecule-1, β-catenin, N-cadherin, E-cadherin, matrix metalloproteinase (MMP)-2 and MMP-9] was determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis. The changes in the expression and subcellular localization of E-cadherin were determined by indirect immunofluorescence. IP6 induced a decrease in the migration ability of the tested SW620 cell line. IP6-treated cells also showed decreased expression of N-cadherin, increased levels of E-cadherin and decreased expression of MMP-2 and MMP-9. These results indicated that IP6 has potential to modulate the migration ability and expression of markers associated with invasion in SW620 cells; however, further analysis is necessary to obtain a detailed understanding of the mechanism of action.
- 650 _2
- $a protinádorové látky $x farmakologie $x terapeutické užití $7 D000970
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a buněčná adheze $x účinky léků $7 D002448
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a pohyb buněk $x účinky léků $7 D002465
- 650 _2
- $a kolorektální nádory $x farmakoterapie $x patologie $7 D015179
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a invazivní růst nádoru $x prevence a kontrola $7 D009361
- 650 _2
- $a kyselina fytová $x farmakologie $x terapeutické užití $7 D010833
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ježková, Alena $u Department of Biochemical Sciences, Charles University, Faculty of Pharmacy, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Rudolf, Emil $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
- 700 1_
- $a Caltová, Kateřina $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
- 700 1_
- $a Králová, Věra $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
- 700 1_
- $a Hanušová, Veronika $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, 500 03 Hradec Králové, Czech Republic.
- 773 0_
- $w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 53, č. 4 (2018), s. 1625-1632
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30066850 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190121104055 $b ABA008
- 999 __
- $a ok $b bmc $g 1364572 $s 1038626
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 53 $c 4 $d 1625-1632 $e 20180719 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
- LZP __
- $a Pubmed-20190107